GLENVIEW CAPITAL MANAGEMENT, LLC
Position in A — Agilent Technologies, Inc.
CIK 1138995
NEW YORK, NY
Position in A
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$261,614,131
New position
Shares Held
1,969,541
first reported quarter
Ownership
0.697%
of shares outstanding
% of Portfolio
5.23%
of 13F equity value
Holder Rank
#26
of 1,112 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Derivatives in A
reported options exposure · as of Jun 30, 2026CallValue
$15,487,978
CallShares
116,600
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026GLENVIEW CAPITAL MANAGEMENT, LLC holds $794,373,256 across 3 Diagnostics & Research names. A ranks #2 (32.9% of the industry book) .
All Filings in A
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $261,614,131 | 1,969,541 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $15,487,978 | 116,600 | Call | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||